Soligenix Stock Forum

$Soligenix (SNGX.US)$
19/11/2024 - 20:30
Phase 3 clinical study of HyBryte™ in CTCL initiating in 2024
PRINCETON, N.J., Nov. 19, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the formation of a European M...

$Soligenix (SNGX.US)$ On Thursday, Soligenix Inc. (NASDAQ:SNGX) opened patient enrollment for its DUS-AUBD-01 Phase 2 study evaluating SGX945 (dusquetide) for Behçet's Disease, an inflammatory disorder of the blood vessels (vasculitis).
The company looks forward to completing enrollment and announcing study results in the first half of 2025.
The pilot clinical trial of SGX945 will be an open-label study that will enroll approximately 25 patients aged 18 years or older with mild to moderate...

$Soligenix (SNGX.US)$
Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease
Soligenix (SNGX) has initiated patient enrollment for a Phase 2 clinical trial evaluating SGX945 (dusquetide) in treating Behçet's Disease.
The study received clearance from both FDA and Turkish authorities. The open-label trial will enroll approximately 25 patients with mild to moderate Behçet's Disease and active oral/genital ulcers.
Patients will receive twice-w...

$Soligenix (SNGX.US)$ fk me! im stuck with 8.36 🥲

$Soligenix (SNGX.US)$ Soligenix Says Hong Kong Patent Office Has Granted Patent Entitled 'Systems And Methods For Producing Synthetic Hypericin'

$Soligenix (SNGX.US)$ Soligenix to Present New Findings on HyBryte for Treating T-Cell Lymphoma at EORTC Meeting October 9th to 11th

$Soligenix (SNGX.US)$ today!

$Soligenix (SNGX.US)$ Hehehe Shorty makin sure we know they are in control! At least until and if volume comes! Hehehe

$Soligenix (SNGX.US)$ gonna go ahead and load up just incase